Twenty-one days of isolation: A prospective observational cohort study of an Ebola-exposed hot zone community in Liberia

Journal of Infection

Volumn 71, Issue 2, 2015, Pages 150-157

  Williams, George Sie ^a   Naiene, Jeremias ^a   Gayflor, Joseph ^b   Malibiche, Theophil ^c   Zoogley, Bentoe ^a   Frank, Wimot G ^b   Nayeri, Fariba ^d,e  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Ministry of Health and Social Welfare   (Liberia)

^c African Union ASEOWA Liberia   (Liberia)

^d Swedish Civil Contingencies Agency Liberia Mission   (Sweden)

^e LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ebola exposed community; Isolation; Response

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COMMUNITY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; EXPOSURE; FATIGUE; FEMALE; FEVER; HUMAN; INFECTION CONTROL; LIBERIA; LOSS OF APPETITE; MALE; NONHUMAN; OBSERVATIONAL STUDY; PATIENT CARE; PROSPECTIVE STUDY; CASE REPORT; DISEASE TRANSMISSION; EPIDEMIOLOGY; HEMORRHAGIC FEVER, EBOLA; INFANT; MIDDLE AGED; PREVENTION AND CONTROL; PROCEDURES; TIME FACTOR; TRANSMISSION;

ADOLESCENT; CHILD; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFANT; INFECTION CONTROL; LIBERIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84937526027     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.05.003     Document Type: Article

References (31)

1. Peters C.J., Sanchez A., Rollin P.E., Ksiazek T.G., Murphy F. Filoviridae, Marburg and Ebola viruses. Fields virology 1996, Raven Press, New York. 3rd ed. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
2. Bull World Health Organ 1978, 56(2):271-293.
3. Formenty P., Leroy E.M., Epelboin A., Libama F., Lenzi M., Sudeck H., et al. Detection of Ebola virus in oral fluid specimens during outbreaks of ebola virus hemorrhagic fever in the Republic of Congo. CID 2006 1 June, 42:1521-1526.
4. Locsin R.C., Matua A.G. The lived experience of waiting-to-know: Ebola at Mbarara, Uganda, hoping for life, anticipating death. J Adv Nurs 2002, 37(2):173-181.
5. Dowell S.F., Mukunu R., Ksiazek T.G., Khan A.S., Rollin P., Peters C.J. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de lute contre les epidemies a kikwit. J Infect Dis 1999, 179(Suppl. 1):S87-91.
6. Bray M., Geisbert T.W. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005, 37:1560-1566.
7. Fisher-Hoch S.P., Platt G.S., Neild G.H., Southee T., Baskerville A., Raymond R.T., et al. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J Infect Dis 1985, 152:887-894.
8. Sobarzo A., Ochayon D.E., Lutwama J.J., Balinandi S., Guttman O., Marks R.S., et al. Persistent immune responses after Ebola virus infection. N Engl J Med 2013, 369:492-493.
9. Baize S., Pannetier D., Oestereich L., Rieger T., Koivoqui L., Maqassouba N., et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014, 371:15.
10. Patel R.B., Burke T.F. Urbanization: an emerging humanitarian disaster. N Engl J Med 2009, 361:741-743.
11. Mitman G. Ebola in a stew of fear. N Engl J Med 2014, 6, 371(19):1763-1765.
12. Lewnard J.A., Ndeffo Mbah M.L., Alfaro-Murillo J.A., Altice F.L., Bawo L., Nyenswah T.G., et al. Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis. Lancet Infect Dis 2014, 14:1189-1195.
13. World Health Organisation. Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa. http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/#.
14. World Health Organisation Statement. Ethical considerations for use of unregistered interventions for Ebola virus disease (EVD). http://www.who.int/mediacentre/news/statements/2014/ebola-ethicalreview-summary/en/.
15. Farrington D.P. Longitudinal research strategies: advantages, problems, and prospects. J Am Acad Child Adolesc Psychiatry 2015, 24:339-434.
16. World Health Organisation. Personal Protective Equipment (PPE) for Ebola Virus Disease (EVD) Frequently Asked Questions (FAQs). http://apps.who.int/iris/bitstream/10665/137410/1/WHO_EVD_Guidance:PPE_14.1_eng.pdf?ua=1%26ua=1.
17. Formenty P., Maurice Leroy E., Epelboin A., Libama F., Lenzi M., Sudeck H., et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. CID 2006, 42:1521-1526.
18. Borchert M., Mutyaba I., Van Kerhove M.D., Lutwama J., Luwaqa H., Bisoborwa G., et al. Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned. BMC Infect Dis 2011, 11:357.
19. Control for Viral Haemorrhagic Fevers in the African Health Care Setting. http://www.cdc.gov/vhf/abroad/pdf/african-healthcare-setting-vhf.pdf.
20. Osuka A., Shimizu K., Ogura H., Tasaki O., Hamasaki T., Asahara T., et al. Prognostic impact of fecal pH in critically ill patients. Crit Care 2012, 16:R119.
21. Sorour A., Lönn J., Nakka S.S., Nayeri T., Nayeri Fl Evaluation of hepatocyte growth factor as a local acute phase response marker in the bowel: the clinical impact of a rapid diagnostic test for immediate identification of acute bowel inflammation. Cytokine 2015, 71(1):8-15.
22. Okware S.I., Omaswa F.G., Zaramba S., Opio A., Lutwama J.J., Kamugisha J., et al. An outbreak of Ebola in Uganda. Trop Med Int Health 2002 Dec, 7(12):1068-1075.
23. Feldmann H., Klenk H.D., Sanchez A. Molecular biology and evolution of filoviruses. Arch Virol Suppl 1993, 7:81-100.
24. Dowell S.F., Mukunu R., Ksiazek T.G., Khan A.S., Rollin P.E., Peters C.J. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999, 179(Suppl. 1):S87-91.
25. Olupot-Olupot P. Ebolainchildren: epidemiology, clinical features, diagnosis and outcomes. Pediatr Infect Dis J 2015, 34(3):314-316.
26. Noyori O., Matsuno K., Kajihara M. Differential potential forenvelopeglycoprotein-mediated steric shielding of host cell surface proteins among filoviruses. Virology 2013, 446(1-2):152-161.
27. Feldmann H., Bugany H., Mahner F., Klenk H.D., Drenckhahn D., Schnittler H.J. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Clin Invest 1996, 70:2208-2214.
28. Baize S., Leroy E.M., Georges-Courbot M.C., Capron M., Lansoud-Soukate J., Debre P., et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999, 5:1-5.
29. Leroy E.M., Baize S., Volchkov V.E., Fisher-Hoch S.P., Georges-Courbot M.C., Lansoud-Soukate J., et al. Human asymptomatic Ebola infection exists and is associated with a strong inflammatory response. Lancet 2000, 355:2210-2215.
30. Tomori O., Bertolli J., Rollin P.E., Fleerackers Y., Guimard Y., De Roo A., et al. Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwik, Democratic Republic of the Congo, 1995. J Infect Dis 1999, 179(1):S98-101.
31. Lyon G.M., Mehta A.K., Varkey J.B., Brantly K., Plyler L., McElroy A.K., et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 2014 Dec 18, 371(25):2402-2409.